Trials / Unknown
UnknownNCT05598190
A577-nm Pro -Yellow Laser In Treatment of Striae Rubra
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 18 (estimated)
- Sponsor
- Al-Azhar University · Academic / Other
- Sex
- Female
- Age
- —
- Healthy volunteers
- Accepted
Summary
Stretch marks or striae are common skin condition occurring in both genders, but they are more prevalent among women. These are linear dermal scars that are accompanied by epidermal atrophy. They usually occur frequently in numerous physiological and pathological conditions, such as adolescent growth, pregnancy, obesity, Cushing disease, Marfan syndrome, and long-term systemic or topical steroid use. Decreased expression of collagen and fibronectin genes has also been associated with striae. The pro-yellow laser systems can be used in a wide range of indications such as facial erythema, facial telangiectasia, port wine stain nevus, rosacea, poikilo derma civatte, and Becker's nevus Some of these indications are clinical lesions in the vascular pattern; some are related to the factors that trigger vascularity, such as vascular endothelial growth factor (VEGF) in etiopathogenesis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Pro-Yellow laser 577 | 4 session for cases with digtal photo before and after sessions |
Timeline
- Start date
- 2022-09-15
- Primary completion
- 2023-09-01
- Completion
- 2023-09-01
- First posted
- 2022-10-28
- Last updated
- 2022-10-28
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05598190. Inclusion in this directory is not an endorsement.